{"id":"NCT02886715","sponsor":"Fougera Pharmaceuticals Inc.","briefTitle":"A Study Comparing Tazarotene Cream 0.1% to TAZORAC速 (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris","officialTitle":"A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to TAZORAC速 (Tazarotene) Cream 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-21","primaryCompletion":"2017-05-31","completion":"2017-05-31","firstPosted":"2016-09-01","resultsPosted":"2018-08-17","lastUpdate":"2018-08-17"},"enrollment":1110,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acne Vulgaris"],"interventions":[{"type":"DRUG","name":"Tazarotene Cream 0.1%","otherNames":["Tazarotene"]},{"type":"DRUG","name":"Tazorac速","otherNames":["Tazarotene"]},{"type":"DRUG","name":"Placebo","otherNames":["Vehicle"]}],"arms":[{"label":"Test","type":"EXPERIMENTAL"},{"label":"Reference","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to TAZORAC速 (Tazarotene) Cream 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris","primaryOutcome":{"measure":"Change in Inflammatory Lesion Counts","timeFrame":"Week 12","effectByArm":[{"arm":"Test","deltaMin":-58.44,"sd":1.33},{"arm":"Reference","deltaMin":-60.07,"sd":1.32},{"arm":"Placebo","deltaMin":-53.28,"sd":1.81}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":"0.0185"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":25,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":442},"commonTop":["Application site dryness","Application site pain","Application site pruritus","Nasopharyngitis","Application site exfoliation"]}}